Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2002
05/10/2002WO2002036595A2 N-(5,7-DIMETHOXY[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YL) ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES
05/10/2002WO2002036555A1 Sulfamides as gamma-secretase inhibitors
05/10/2002WO2002020437A3 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them
05/10/2002WO2001041768A3 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments
05/10/2002WO2001029036A3 Allosteric sites on muscarinic receptors
05/10/2002WO2001023389A3 Certain alkylene diamine-substituted heterocycles
05/10/2002WO2001023386A3 Benzodiazepin derivatives, the production and use thereof
05/10/2002WO2001000186A3 New use of 1,2,4-triazolo'1,5-a! pyrimidines
05/09/2002US20020055630 Process for preparation of cyclopenta [b] [1,4] diazepino [6,7,1-hi] indole derivatives
05/09/2002US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/09/2002US20020055511 Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
05/09/2002US20020055504 Acylating a cyclopentaindolemethylamine and cyclizing and reducing the product
05/09/2002US20020055501 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome.
05/08/2002EP1202994A1 New compounds
05/08/2002EP1202977A2 Process for manufacturing diazepine derivatives
05/08/2002EP1202976A1 Pyrazinones, compositions containing such compounds
05/08/2002EP0888301A4 Mcbi analogs of cc-1065 and the duocarmycins
05/08/2002CN1348456A Phthalocyanine compounds, water-base ink compositions and coloured products
05/08/2002CN1348455A Pyrazolobenzodiazepines as CDK2 inhibitors
05/08/2002CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/08/2002CN1084334C Soluble phthalocyanine capable of stably storing
05/07/2002US6384235 Preparation of substituted indoles
05/07/2002US6384234 Halogenation
05/07/2002US6384228 Method for synthesis of halopyridyl-azacyclopentane derivative and intermediate thereof
05/07/2002US6384221 Recrystallization purification
05/07/2002US6384219 1H-pyrrolo-[1,2-b][1,2,4,]triazole compound and its synthetic intermediate, and method of preparing a 1H-1,2,4-triazole-5-yl-acetic acid ester compound
05/07/2002US6384041 Bicyclic sPLA2 inhibitors
05/07/2002US6384027 Phthalocyanine analogs
05/07/2002US6383790 Pyrazolo(3,4-d)pyrimidine based compound; anticarcinogenic agents; antitumor agents
05/07/2002CA2216535C Protein kinase c inhibitors
05/07/2002CA2098612C Arthropodicidal carboxanilides
05/07/2002CA2052263C Herbicides
05/02/2002WO2002042244A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
05/02/2002WO2002035454A1 Fluoroscopic registration artifact with optical and/or magnetic markers
05/02/2002WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002WO2002034752A1 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]benzodiazepines
05/02/2002WO2002034751A1 Hexahydro-4-oxoazepino[3,2,1-hi]indoles
05/02/2002WO2002034725A1 Substituted phenyluracils
05/02/2002WO2002034718A1 Amide derivatives as nmda receptor antagonists
05/02/2002WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
05/02/2002WO2002020525A3 Protein tyrosine phosphatase inhibitor
05/02/2002WO2002002562A3 Heteropolycyclic inhibitors
05/02/2002WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
05/02/2002WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/02/2002US20020052512 Diaminopropionic acid derivatives
05/02/2002US20020052495 Pyramidine or triazine derivatives which specifically inhibit the binding of endothelin to the receptor
05/02/2002US20020052384 Furopyrimidines and pyrrolopyrimidines; treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients.
05/02/2002US20020052364 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors
05/02/2002US20020052355 Inhibition of serotonin reuptake; especially 2-(azabicycloalkyl)alkylenyl)isoquinolin-3-one compounds
05/02/2002US20020052351 Novel medical use for tachykinin antagonists
05/02/2002US20020051948 Silver halide color photographic lightsensitive material and compound used therein
05/02/2002EP1201650A2 Ionic malonitril derivatives and their uses
05/02/2002EP1201649A1 Glucocorticoid receptor modulators
05/02/2002EP1200824A1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
05/02/2002EP1200440A1 Quinuclidine derivatives for treatment of neurological disorders
05/02/2002EP1200439A1 1,2-dihydro-1-oxo-parazino(1,2-a) indole derivatives
05/02/2002EP1200438A2 Method for making debromohymenialdisine and analogs thereof
05/02/2002EP1200417A1 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
05/02/2002EP1200091A1 Beta-carboline pharmaceutical compositions
05/02/2002EP1200090A1 Beta-carboline pharmaceutical compositions
05/02/2002EP0888359B1 Pyrimidin-4-one derivatives as pesticide
05/02/2002EP0847271B1 PYRAZOLO-(1,5-a)-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND HAIR DYES CONTAINING THESE
05/02/2002EP0840740B1 New inhibitors of platelet aggregation
05/02/2002DE10051981A1 Substituierte Phenyluracile Substituted Phenyluracils
05/02/2002CA2427473A1 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
05/02/2002CA2425884A1 Substituted phenyluracils
05/02/2002CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity
05/02/2002CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002CA2422950A1 Fluoroscopic registration artifact with optical and/or magnetic markers
05/01/2002CN1347010A Color photographic sensitive silver halide material, pyrrolotriazole compound and color formation compound
05/01/2002CN1083842C [1,2,4] triazolo [4,3-a] quinoxalinone derivs., their preparation and use
04/2002
04/30/2002US6381169 High density non-volatile memory device
04/30/2002US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy
04/30/2002US6380228 E.g., n-(2-phenylsulfonyl-1-ethyl)-3-(4-cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta
04/30/2002US6380211 For treating diabetes
04/30/2002US6380203 Angiogenesis inhibitors
04/30/2002US6380202 Selective fungicidal activity and high systemicity
04/30/2002US6380186 Psychotherapeutic agents
04/30/2002US6380180 Potassium channel blocking agents
04/30/2002US6380134 N-pyridyl herbicide compounds
04/30/2002US6379397 Capable of generating intense colorings in varied shades
04/25/2002WO2002032904A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents
04/25/2002WO2002032903A1 Method for producing trimer of indole derivative, and trimer of indole derivative and laminated structure thereof
04/25/2002WO2002032902A1 3,8-diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias
04/25/2002WO2002032901A2 Bridged piperazine derivatives
04/25/2002WO2002032895A1 Chemical compounds
04/25/2002WO2002032872A1 Nitrogenous aromatic ring compounds
04/25/2002WO2002032863A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/25/2002WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
04/25/2002US20020049335 DNA alkylating compounds such as 1-(tert-butyloxycarbonyl) -4-hydroxy-3(((methane-sulfonyl)oxy)methyl)-2,3-dihydroindole
04/25/2002US20020049318 6-phenyl-pyrazolopyrimidines
04/25/2002US20020049308 Novel macrocyclic magnetic resonance imaging contrast agents
04/25/2002US20020049246 Benzimidazole compounds for treatment of asthma, vasospasm, memory loss, migraine and others diseases associated with potassium channels
04/25/2002US20020049227 Pyrazoles and pyrazolopyrimidines having crf antagonistic activity
04/25/2002US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression
04/25/2002US20020049212 Benzimidazole compounds and salts containing piperidine ring are useful in treatment or prevention or medical conditions selected from pain, and inflammatoy diseases; analgesics
04/25/2002US20020049208 Imidazo[1,2-a]pyrazines for the treatment of neurological disorders
04/25/2002US20020049207 Nitrogen containing heterobicyclic compounds for treating disorders manifesting hypersecretion of corticotropin releasign factor(CRF) in a warm-blooded animals, such as stroke
04/25/2002US20020049196 Hexahydro-pyrazolo-(4,3-c)pyridine derivatives useful for increasing the endogenous production or release of growth hormone in a human or other animal, thus treat or prevent osteoporosis